Swiss authorities said Tuesday they had begun assessing AstraZeneca and Oxford University's COVID-19 vaccine—the first such treatment submitted for authorisation in the country.
Oct 6, 2020
0
5
During the 2016 Zika outbreak, news exposure appears to have had a far bigger impact than local disease risk on the number of times people visited Zika-related Wikipedia pages in the U.S. Michele Tizzoni and colleagues at ...
Mar 12, 2020
0
81
The World Health Organization (WHO) recently declared an international public health emergency over the global outbreak of the novel coronavirus. One day later, the Wellcome Trust research charity called for researchers, ...
Feb 25, 2020
0
5
The Food and Drug Administration announced it is shutting down its controversial "alternative summary reporting" program and ending its decades-long practice of allowing medical device makers to conceal millions of reports ...
May 6, 2019
0
0
A team of researchers from the Department of Energy's Oak Ridge National Laboratory Health Data Sciences Institute has harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
Mar 11, 2019
0
5
Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system.
Nov 27, 2018
0
39
When assessing the effects of socioeconomic status (SES) on health inequalities or outcomes of care, it is worthwhile to use small-area-based open data instead of individual SES information, according to a new study from ...
Nov 27, 2018
0
0
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
Nov 7, 2018
0
90
Scientists at UC San Francisco have painstakingly assembled a searchable database of normal human immunity that researchers can now use as an instant comparison group in studies of the immune system and immune dysfunction. ...
Oct 9, 2018
0
3
The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. ...
Aug 5, 2017
0
41
